1Reichart PA, Van Wyk CW, Becker J, et al. Distribution of procollagen type Ⅲ, collagen type VI and tenascin in oral submucous fibrosis (OSF) [J]. J Oral Pathol Med, 1994, 23 (9) : 394-398.
5Kawaguchi Y, Suzukik K, Hara H,et al.Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis[J] .Ann Rheum Dis, 1994,53 (38) : 506-510.
10Haque MF, Harris M, Meghji S, et al. Immunolocalization of cytokines and growth factors in oral submucous fibrosis [J]. Cytokine,1998, 10(9) :713-719.
2Kamath VV.Surgical interventions in oral submucous fi- brosis: a systematic analysis of the literature[J].J Maxil- lofac Oral Surg,2015,14(3):521-531.
3Krupaa RJ,Sankari SL, Masthan KM, et al.Oral lichen planus : An overview[J].J Pharm Bioallied Sci, 2015 , 7(Suppl 1):S158-S161.
4Shivakumar HR, Batra J , Upasi AP,et al.Evaluation of e- longated styloid process in patients with oral submucous fibrosis using panoramic radiographs[J].J Maxillofac O- ral Surg,2014,13(4):556-559.
5Yanjia H,Xinchun J.The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral sub- mucous fibrosis[J].Clin Chim Acta,2007,383(1/2): 51-56.
6Keshav R, Narayanappa U.Expression of proliferating cell nuclear antigen(PCNA)in oral submucous fibrosis : an immunohistochemical study[J].J Clin Diagn Res,2015,9(5):ZC20-ZC23.
8Meier JA, Larner AC.Toward a new STATe: the role of STATs in mitochondrial function[J].Semin Immunol, 2014,26(1):20-28.
9Qi ZL,Yin F, Lu LA,et al.Baicalein reduces lipopolysac- charide-induced inflammation via suppressing JAK/ STATs activation and ROS production[J].Inflamm Res,2013,62(9):845-855.
10Livak KJ,Schmittgen TD.Analysis of relative gene ex- pression data using real-time quantitative PCR and the 2[-Delta Delta C(T)]method[J].Methods, 2001,25(4):402-408.
